Eileen B. Brown

2.2k total citations
17 papers, 866 citations indexed

About

Eileen B. Brown is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Eileen B. Brown has authored 17 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 5 papers in Clinical Psychology. Recurrent topics in Eileen B. Brown's work include Treatment of Major Depression (5 papers), Bipolar Disorder and Treatment (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). Eileen B. Brown is often cited by papers focused on Treatment of Major Depression (5 papers), Bipolar Disorder and Treatment (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). Eileen B. Brown collaborates with scholars based in United States, Switzerland and Canada. Eileen B. Brown's co-authors include Ferenc Martényi, Stephanie C. Koke, Harry Zhang, Apurva Prakash, Dianna D. Cody, Michael Flynn, Mauricio Tohen, Steven A. Goldstein, Craig Mallinckrodt and Madelaine M. Wohlreich and has published in prestigious journals such as Spine, European Heart Journal and The British Journal of Psychiatry.

In The Last Decade

Eileen B. Brown

16 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eileen B. Brown United States 13 311 302 265 110 73 17 866
Alfredo Ortega‐Alonso Finland 18 378 1.2× 304 1.0× 39 0.1× 30 0.3× 61 0.8× 44 1.0k
Deborah Quail United Kingdom 20 265 0.9× 359 1.2× 58 0.2× 173 1.6× 48 0.7× 44 1.2k
Daniel N. Masica United States 14 249 0.8× 336 1.1× 198 0.7× 129 1.2× 255 3.5× 23 1.1k
Marko Martinac Bosnia and Herzegovina 14 154 0.5× 35 0.1× 226 0.9× 40 0.4× 14 0.2× 56 672
Angela Gentili United States 15 173 0.6× 196 0.6× 50 0.2× 60 0.5× 17 0.2× 27 736
Stan Krulewicz United States 12 235 0.8× 210 0.7× 216 0.8× 78 0.7× 2 0.0× 27 666
Wiebke Greggersen Germany 14 131 0.4× 36 0.1× 178 0.7× 49 0.4× 53 0.7× 16 540
A. J. Clark Canada 14 125 0.4× 381 1.3× 47 0.2× 44 0.4× 6 0.1× 24 833
Scott Mist United States 18 556 1.8× 462 1.5× 157 0.6× 33 0.3× 28 0.4× 46 1.1k
J. P. R. Young United Kingdom 10 406 1.3× 161 0.5× 60 0.2× 84 0.8× 25 0.3× 21 878

Countries citing papers authored by Eileen B. Brown

Since Specialization
Citations

This map shows the geographic impact of Eileen B. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen B. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen B. Brown more than expected).

Fields of papers citing papers by Eileen B. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen B. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen B. Brown. The network helps show where Eileen B. Brown may publish in the future.

Co-authorship network of co-authors of Eileen B. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen B. Brown. A scholar is included among the top collaborators of Eileen B. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen B. Brown. Eileen B. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Goldstein, S., L. Kristin Newby, Derek D. Cyr, et al.. (2017). Relationship Between Peak Troponin Values and Long‐Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes. Journal of the American Heart Association. 6(4). 7 indexed citations
2.
Bakal, Jeffrey A., E. Magnus Ohman, Shaun G. Goodman, et al.. (2014). Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial. European Heart Journal. 36(6). 385–392. 35 indexed citations
3.
Martényi, Ferenc, et al.. (2007). Failed Efficacy of Fluoxetine in the Treatment of Posttraumatic Stress Disorder. Journal of Clinical Psychopharmacology. 27(2). 166–170. 41 indexed citations
4.
Brown, Eileen B., Susan L. McElroy, Paul E. Keck, et al.. (2006). A 7-Week, Randomized, Double-Blind Trial of Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression. The Journal of Clinical Psychiatry. 67(7). 1025–1033. 130 indexed citations
5.
Perlis, Roy H., Robert W. Baker, Carlos A. Zarate, et al.. (2006). Olanzapine Versus Risperidone in the Treatment of Manic or Mixed States in Bipolar I Disorder. The Journal of Clinical Psychiatry. 67(11). 1747–1753. 63 indexed citations
6.
Heiligenstein, John H., S. Hoog, Karen Dineen Wagner, et al.. (2006). Fluoxetine 40–60 mg versus Fluoxetine 20 mg in the Treatment of Children and Adolescents with a Less-Than-Complete Response to Nine-Week Treatment with Fluoxetine 10–20 mg: APilot Study. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 207–217. 22 indexed citations
7.
Nilsson, Mary, et al.. (2004). Safety of Subchronic Treatment with Fluoxetine for Major Depressive Disorder in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. 14(3). 412–417. 32 indexed citations
8.
Brannan, Stephen K., Craig Mallinckrodt, Eileen B. Brown, et al.. (2004). Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. Journal of Psychiatric Research. 39(1). 43–53. 149 indexed citations
9.
Nilsson, Mary, et al.. (2004). Safety of Subchronic Treatment with Fluoxetine for Major Depressive Disorder in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. 14(3). 412–417. 2 indexed citations
10.
Brown, Eileen B., et al.. (2004). P.2.015 Olanzapine versus risper idone in the treatment of bipolar I disorder: Determinants of change in severity of bipolar illness ratings. European Neuropsychopharmacology. 14. S238–S239. 1 indexed citations
11.
Pearlstein, Teri, et al.. (2003). Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment. American Journal of Obstetrics and Gynecology. 188(4). 887–895. 17 indexed citations
12.
Brown, Eileen B., et al.. (2002). Switching Patients From Daily Citalopram, Paroxetine, or Sertraline to Once-Weekly Fluoxetine in the Maintenance of Response for Depression. The Journal of Clinical Psychiatry. 63(3). 232–240. 16 indexed citations
13.
Martényi, Ferenc, Eileen B. Brown, Harry Zhang, Apurva Prakash, & Stephanie C. Koke. (2002). Fluoxetine Versus Placebo in Posttraumatic Stress Disorder. The Journal of Clinical Psychiatry. 63(3). 199–206. 130 indexed citations
14.
Martényi, Ferenc, Eileen B. Brown, Harry Zhang, Stephanie C. Koke, & Apurva Prakash. (2002). Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. The British Journal of Psychiatry. 181(4). 315–320. 85 indexed citations
15.
Koke, Stephanie C., et al.. (2002). Safety and efficacy of fluoxetine in patients who receive oral contraceptive therapy. American Journal of Obstetrics and Gynecology. 187(3). 551–555. 11 indexed citations
16.
Brown, Eileen B., et al.. (1997). TOLERANCE INTERVALS FOR ASSESSING INDIVIDUAL BIOEQUIVALENCE. Statistics in Medicine. 16(7). 803–820. 14 indexed citations
17.
Cody, Dianna D., Steven A. Goldstein, Michael Flynn, & Eileen B. Brown. (1991). Correlations Between Vertebral Regional Bone Mineral Density (rBMD) and Whole Bone Fracture Load. Spine. 16(2). 146–154. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfredo Ortega‐Alonso Breakdown of academic impact, for papers by Deborah Quail Breakdown of academic impact, for papers by Daniel N. Masica Breakdown of academic impact, for papers by Marko Martinac Breakdown of academic impact, for papers by Angela Gentili Breakdown of academic impact, for papers by Stan Krulewicz Breakdown of academic impact, for papers by Wiebke Greggersen Breakdown of academic impact, for papers by A. J. Clark Breakdown of academic impact, for papers by Scott Mist Breakdown of academic impact, for papers by J. P. R. Young
Rankless by CCL
2026